Korean practice guidelines for gastric cancer 2022: an evidence-based, multidisciplinary approach

TH Kim, IH Kim, SJ Kang, M Choi, BH Kim… - Journal of gastric …, 2023 - pmc.ncbi.nlm.nih.gov
Gastric cancer is one of the most common cancers in Korea and the world. Since 2004, this
is the 4th gastric cancer guideline published in Korea which is the revised version of …

Korean practice guideline for gastric cancer 2018: an evidence-based, multi-disciplinary approach

… Committee of the Korean Gastric Cancer … - Journal of gastric …, 2019 - synapse.koreamed.org
Background Gastric cancer is the most common cancer and the fourth most common cause
of cancer death in South Korea [1]. Despite the large number of gastric cancer patients …

[HTML][HTML] Gastric cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up

EC Smyth, M Verheij, W Allum, D Cunningham… - Annals of oncology, 2016 - Elsevier
Almost one million (951 600) new cases of gastric cancer were diagnosed globally in 2012,
resulting in∼ 723 100 deaths [1]. Of these∼ 140 000 cases and∼ 107 000 deaths occurred …

The Chinese Society of Clinical Oncology (CSCO): clinical guidelines for the diagnosis and treatment of gastric cancer

FH Wang, L Shen, J Li, ZW Zhou, H Liang… - Cancer …, 2019 - Springer
China is one of the countries with the highest incidence of gastric cancer. There are
differences in epidemiological characteristics, clinicopathological features, tumor biological …

Organoid cultures recapitulate esophageal adenocarcinoma heterogeneity providing a model for clonality studies and precision therapeutics

X Li, HE Francies, M Secrier, J Perner… - Nature …, 2018 - nature.com
Esophageal adenocarcinoma (EAC) incidence is increasing while 5-year survival rates
remain less than 15%. A lack of experimental models has hampered progress. We have …

Adjuvant capecitabine plus oxaliplatin for gastric cancer after D2 gastrectomy (CLASSIC): 5-year follow-up of an open-label, randomised phase 3 trial

SH Noh, SR Park, HK Yang, HC Chung… - The lancet …, 2014 - thelancet.com
Background The CLASSIC trial was done to compare adjuvant capecitabine plus oxaliplatin
versus observation after D2 gastrectomy for patients with stage II or III gastric cancer. The …

British Society of Gastroenterology guidelines on the diagnosis and management of Barrett's oesophagus

RC Fitzgerald, M Di Pietro, K Ragunath, Y Ang… - Gut, 2014 - gut.bmj.com
These guidelines provide a practical and evidence-based resource for the management of
patients with Barrett's oesophagus and related early neoplasia. The Appraisal of Guidelines …

Oesophageal cancer

J Lagergren, E Smyth, D Cunningham, P Lagergren - The Lancet, 2017 - thelancet.com
Oesophageal cancer is a clinically challenging disease that requires a multidisciplinary
approach. Extensive treatment might be associated with a considerable decline in health …

Esophageal cancer

MW Short, KG Burgers, VT Fry - American family physician, 2017 - aafp.org
Esophageal cancer has a poor prognosis and high mortality rate, with an estimated 16,910
new cases and 15,910 deaths projected in 2016 in the United States. Squamous cell …

Recent developments in esophageal adenocarcinoma

J Lagergren, P Lagergren - CA: a cancer journal for clinicians, 2013 - Wiley Online Library
Answer questions and earn CME/CNE Esophageal adenocarcinoma (EAC) is characterized
by 6 striking features: increasing incidence, male predominance, lack of preventive …